Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 35 | $44,258,207 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Nov 2024 17:31 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 14 Nov 2024 | Sale | 583 | 33.1 | 19,297 | I |
| 18 Nov 2024 17:31 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 14 Nov 2024 | Sale | 4 | 33.1 | 132 | I |
| 18 Nov 2024 17:31 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 14 Nov 2024 | Sale | 123 | 33.1 | 4,071 | I |
| 18 Nov 2024 17:31 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 14 Nov 2024 | Sale | 72 | 33.1 | 2,383 | I |
| 05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
| 05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 29,435 | 30.05 | 884,522 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | I |
| 28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | I |
| 23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | I |
| 20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | I |
| 20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | I |
| 20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | I |
| 20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | I |
| 20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)